Curaleaf Holdings Inc Stock News

OTC stocks often go unnoticed as there is an ocean of ideas to research and buy from the main exchanges. That's understandable also because liquidity is higher in the main exchanges as compared to the

It is a good Monday for Cannabis stocks. Canopy Growth (CGC), Curaleaf (CURLF),  and Aurora Cannabis (ACB) stock prices surged by more than 10% in the pre-market session.

Cannabis stocks have gone through multiple phases of high volatility in the last five years. Traders might have benefited from this volatility, but the sector has disappointed long-term investors.

As we head for the second quarter of 2024, the US cannabis industry and top marijuana stocks offer intriguing investment opportunities amid evolving legal landscapes and consumer trends. Top cannabis

Curaleaf's share price has doubled since early February 2024, defying a bearish outlook. The lack of federal legalization is hindering the U.S. cannabis industry's growth potential. CURLF's market cap

Curaleaf Holdings, Inc. (OTCPK:CURLF) Q4 2023 Earnings Conference Call March 6, 2024 5:00 PM ET Corporate Participants Camilo Lyon - Chief Investment Officer Boris Jordan - Executive Chairman Matt Dar

Curaleaf Holdings, Inc. (CURLF) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.23 per share a year ago.

Marijuana stock investors have been riding the moment wave. What this means is that since the start of the new year, there have been several reasons why momentum is building. To start it is the specul

As excitement builds, U.S. federal agencies are looking to revise cannabis regulations. Support for cannabis legalization has surged to unprecedented levels, which bodes incredibly well for cannabis s

A deeper study of the penny stock universe reveals some quality names that are under the radar and undervalued. By quality, I mean good fundamentals and a business that holds potential for growth in t

The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS ) has surged by nearly 30% year-to-date, showcasing the rejuvenated demand for cannabis stocks. Salient to the ETF's year-to-date performance has

Marijuana stocks have begun to see slight increases in momentum. But what is causing this build-up in trading momentum? It can be due to a few factors that can hurt the cannabis sector. Much of the tr

Starting Many off the new week we hope to see good momentum for the cannabis sector. Many of the top publicly traded cannabis companies are soon to release quarterly earnings while some already have.

Newly released documents indicate that the U.S. Food and Drug Administration (FDA) has “determined that cannabis has a legitimate medical use and that it should be moved from Schedule I to Schedule

Nick Gastevich helps retail investors navigate the cannabis industry and discusses companies that protect shareholders. Green Thumb, Trulieve, Curaleaf, Glass House, and Jushi - what's working, what's